🇺🇸 FDA
Pipeline program

Avastin 25 mg/ml concentrate for solution for infusion., Tecentriq 1 200 mg concentrate for solution for infusion

ABC-HCC

Phase 3 small_molecule active

Quick answer

Avastin 25 mg/ml concentrate for solution for infusion., Tecentriq 1 200 mg concentrate for solution for infusion for intermediate-stage hepatocellular carcinoma is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
intermediate-stage hepatocellular carcinoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials